COX-2 polymorphisms and colorectal cancer risk: A strategy for chemoprevention

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 5, 2010, Pages 607-613

  Pereira, Carina ^a,c   Pimentel Nunes, Pedro ^b,d   Brandão, Catarina ^b   Moreira Dias, Luís ^b   Medeiros, Rui ^a,f   Dinis Ribeiro, Mário ^b,e  

^a Molecular Oncology Group   (Austria)

^b Portuguese Institute of Oncology   (Austria)

^c Núcleo Regional Do Norte ^*  (Austria)

^d Physiology Department   (Canada)

^e University of Porto   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Genetic susceptibility; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 2; GENOMIC DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS; DISEASE PREDISPOSITION; DNA EXTRACTION; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIFESTYLE AND RELATED PHENOMENA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 77951282598     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283352cbb     Document Type: Article

References (35)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press; 2004.
2. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31:925-943.
3. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005; 365:153-165.
4. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med. 1998; 104:2S-8S.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994; 107:1183-1188.
6. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356:2131-2142.
7. Markowitz SD. Aspirin and colon cancer-targeting prevention? N Engl J Med 2007; 356:2195-2198.
8. Pereira C, Medeiros RM, Dinis-Ribeiro MJ. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J Gastroenterol Hepatol 2009; 21:76-91.
9. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002; 22:1631-1636.
10. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 2005; 129:565-576.
11. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Posttranscriptional control of cyclooxygenase-2 gene expression. The role of the 30-untranslated region. J Biol Chem 2000; 275:11750-11757.
12. Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, et al. The cyclooxygenase-2 (PTGS2) 8473T >C polymorphism is associated with breast cancer risk. Clin Cancer Res 2006; 12:1392-1394.
13. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A, Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004; 25:229-235. (Pubitemid 38239806)
14. Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C, et al. -765G >C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol 2006; 12:5473-5478.
15. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO technical report series 894. Geneva: World Health Organization; 2000.
16. Rodríguez LAG TL. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007; 132:498-506.
17. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348:883-890. (Pubitemid 36297996)
18. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348:891-899.
19. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369:1603-1613.
20. Cox DG, Pontes C, Guino E, Navarro M, Navarro M, Osorio A, et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/ COX2) and risk of colorectal cancer. Br J Cancer 2004; 91:339-343.
21. Hoff JM, te Morsche RHM, Roelofs HMJ, von der Logt EMJ, Nagengast FM. Peters WHM. COX-2 polymorphisms -765G-C and - 1195A-G and colorectal cancer risk. World J Gastroenterol 2009; 15:4561-4565.
22. Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 2004; 114:248-253.
23. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 30-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A 1986; 83:1670-1674.
24. Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van DM, van Kranen HJ. Polymorphisms in the genes involved in the arachidonic acidpathway, fish consumption and the risk of colorectal cancer. Int J Cancer 2006; 119:297-303.
25. Kury S, Buecher B, Robiou-du-Pont S, Scoul C, Colman H, Le Neel T, et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 2008; 8:326.
26. Peters WH, te Morsche RH, Roelofs HM, Mathus-Vliegen EM, Berhout M, Nagengest FM. COX-2 polymorphisms in patients with familial adenomatous polyposis. Oncol Res 2009; 17:347-351.
27. TanW,Wu J, Zhang X, Liu J, Sun T, Zhang B, et al. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 2007; 28:1197-1201.
28. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, Ma J, et al. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 2006; 130:1975-1984.
29. Zhang XM, Miao XP, Tan W, Sun T, Guo YL, Zhao D, et al. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28:119-123.
30. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300:2765-2778.
31. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008; 134:388-395.
32. Martey CA, Pollock SJ, Turner CK, O'Reilly KM, Baglole CJ, Phipps RP, Sime PJ Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 2004; 287:L981-L991.
33. Wong HP, Yu L, Lam EK, Tai EK,Wu WK, Cho CH Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 2007; 97:279-287.
34. Yan Z, Subbaramaiah K, Camilli T, Zhang F, Tanabe T, McCaffery TA, et al. Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB. J Biol Chem 2000; 275:4949-4955.
35. Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 2005; 128:1445-1461